Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LODOCO | AGEPHA PHARMA FZ | N-215727 RX | 2023-06-16 | 1 products, RLD, RS |
MITIGARE | Hikma Pharmaceuticals | N-204820 RX | 2014-09-26 | 1 products, RLD, RS |
GLOPERBA | Scilex Pharmaceuticals | N-210942 RX | 2019-01-30 | 1 products, RLD, RS |
COLCRYS | Takeda | N-022352 RX | 2009-07-29 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COLBENEMID | Merck KGaA | N-012383 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
colchicine | NDA authorized generic | 2024-01-10 |
colcrys | New Drug Application | 2023-12-29 |
gloperba | New Drug Application | 2023-12-28 |
lodoco | New Drug Application | 2023-08-24 |
mitigare | New Drug Application | 2023-11-20 |
probenecid and colchicine | ANDA | 2023-11-06 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
amyloidosis | EFO_1001875 | D000686 | E85 |
biliary liver cirrhosis | — | D008105 | K74.3 |
familial mediterranean fever | — | D010505 | M04.1 |
gout | EFO_0004274 | D006073 | M10 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Colchicine, Gloperba, Scilex Pharms | |||
10226423 | 2037-12-20 | DP | |
9907751 | 2036-11-22 | DP | |
10383820 | 2036-11-22 | DP | U-2814 |
10383821 | 2036-11-22 | DP | |
Colchicine, Lodoco, Agepha Pharma Fz | |||
9744144 | 2035-01-22 | U-3643 | |
10206891 | 2035-01-22 | U-3641 | |
10265281 | 2035-01-22 | U-3639 | |
10842762 | 2035-01-22 | U-3640 | |
11026899 | 2035-01-22 | U-3639 | |
11026900 | 2035-01-22 | U-3639 | |
11026901 | 2035-01-22 | U-3638 | |
10130585 | 2034-12-31 | U-3642 | |
Colchicine, Mitigare, Hikma Intl Pharms | |||
8927607 | 2033-08-22 | U-1020 | |
9399036 | 2033-08-22 | U-1020 | |
9555029 | 2033-08-22 | U-1020 | |
9675613 | 2033-08-22 | U-1020 | |
9789108 | 2033-08-22 | U-1020 | |
Colchicine, Colcrys, Takeda Pharms Usa | |||
7820681 | 2029-02-17 | U-1020 | |
7906519 | 2029-02-17 | U-1116 | |
7915269 | 2029-02-17 | U-1007 | |
8440721 | 2029-02-17 | U-1007 | |
8440722 | 2029-02-17 | U-1020 | |
7601758 | 2029-02-10 | U-1007 | |
7619004 | 2028-12-03 | U-1020 | |
7935731 | 2028-12-03 | U-1116 | |
7964647 | 2028-10-06 | U-1007 | |
7964648 | 2028-10-06 | U-1161 | |
7981938 | 2028-10-06 | U-1166 | |
8093296 | 2028-10-06 | U-1007 | |
8093297 | 2028-10-06 | U-1161 | |
8093298 | 2028-10-06 | U-1116 | |
8097655 | 2028-10-06 | U-1020 | |
8415395 | 2028-10-06 | U-1007 | |
8415396 | 2028-10-06 | U-1007 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 4 | 12 | 9 | 2 | 7 | 29 |
Gout | D006073 | EFO_0004274 | M10 | 4 | 10 | 2 | 9 | 3 | 28 |
Coronary artery disease | D003324 | — | I25.1 | — | 4 | 5 | 7 | 1 | 17 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | 3 | 13 | 1 | 1 | 17 |
Pharmacokinetics | D010599 | — | — | 12 | — | — | 1 | — | 13 |
Familial mediterranean fever | D010505 | — | M04.1 | 1 | 5 | 1 | 1 | 5 | 13 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | 3 | 2 | 5 | 1 | 10 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 3 | 4 | 1 | 2 | 9 |
Healthy volunteers/patients | — | — | — | 7 | — | — | 2 | — | 9 |
Pericarditis | D010493 | EFO_0007427 | I30 | 1 | 1 | 3 | 2 | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | 1 | 5 | 4 | — | 1 | 10 |
Heart failure | D006333 | HP_0001635 | I50 | — | 2 | 3 | — | 1 | 6 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 2 | 4 | — | — | 6 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 3 | — | — | 3 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | — | 2 | — | — | 2 |
Severe acute respiratory syndrome | D045169 | EFO_0000694 | J12.81 | — | — | 2 | — | — | 2 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | 1 | — | 1 | 2 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | 1 | — | 1 | 2 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | 1 | 1 | — | — | 2 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperuricemia | D033461 | HP_0002149 | — | 1 | 3 | — | — | — | 4 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | 1 | 2 | — | — | 1 | 3 |
Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | 3 | — | — | — | 3 |
Behcet syndrome | D001528 | EFO_0003780 | M35.2 | — | 2 | — | — | 1 | 3 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | — | — | 1 | 2 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | 2 | — | — | — | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 2 | — | — | — | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 2 | — | — | — | 2 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | 1 | 2 |
Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pneumonia | D011014 | EFO_0003106 | — | 1 | — | — | — | 1 | 2 |
Hypertriglyceridemia | D015228 | EFO_0004211 | — | 1 | — | — | — | — | 1 |
Renal replacement therapy | D017582 | — | — | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Radiotherapy | D011878 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 1 | 1 |
Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 1 | 1 |
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 1 | 1 |
Down syndrome | D004314 | EFO_0001064 | Q90 | — | — | — | — | 1 | 1 |
Mucocutaneous lymph node syndrome | D009080 | EFO_0004246 | M30.3 | — | — | — | — | 1 | 1 |
Hyperaldosteronism | D006929 | HP_0011736 | E26 | — | — | — | — | 1 | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | — | — | — | — | 1 | 1 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 1 | 1 |
Hyperphosphatemia | D054559 | HP_0002905 | — | — | — | — | — | 1 | 1 |
Drug common name | Colchicine |
INN | — |
Description | (S)-colchicine is a colchicine that has (S)-configuration. It is a secondary metabolite, has anti-inflammatory properties and is used to treat gout, crystal-induced joint inflammation, familial Mediterranean fever, and many other conditions. It has a role as a mutagen, an anti-inflammatory agent and a gout suppressant. It is a colchicine and an alkaloid. It is an enantiomer of a (R)-colchicine. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2 |